Share this article
Share this article
ResearchAndMarkets.com s offering.
The global PCR and realtime PCR testing market is expected to decline from $22.53 billion in 2020 to $9.98 billion in 2021 at a compound annual growth rate (CAGR) of -55.7%.
The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $13.82 billion in 2025 at a CAGR of 8.5%.
The RT-PCR test is necessary for qualitative detection of nucleic acid from SARS-CoV-2 in upper and lower respiratory specimens that is collected from individuals suspected of COVID-19.
Share this article
Share this article
ResearchAndMarkets.com s offering.
CRISPR Technology Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global crispr technology market.
Major players in the CRISPR technology market are Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc., Integrated DNA Technologies, Inc. (Danaher), Origene Technologies, Inc., Transposagenbio Biopharmaceuticals (Hera Biolabs), Intellia Therapeutics Inc., and GeneCopoeia, Inc.
The global CRISPR technology market is expected to increase from $0.76 billion in 2019 to $0.92 billion in 2020 at a compound annual growth rate (CAGR) of 20.91%. The exponential growth is mainly due to the COVID-19 outbreak that has led to the research for drugs for COVID-19 with gene-editing using CRISPR technology. The market is expected to reach